Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Paragon Care Limited ( (AU:PGC) ).
Paragon Care Limited has corrected three previously lodged Appendix 3Y Change of Director’s Interest Notices after identifying an administrative error in how certain director share transactions were described. The company stated that trades reported on 23 and 24 December 2025 were incorrectly recorded as on‑market transactions and have now been reclassified as off‑market trades, with no other alterations to the original disclosures, signalling that the underlying holdings data remains unchanged for investors and regulators.
The most recent analyst rating on (AU:PGC) stock is a Hold with a A$0.20 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited (ASX:PGC) is an Australian-listed healthcare company supplying medical equipment, devices, consumables, pharmaceuticals, complementary medicines, nutritional products, and manufacturing blood bank diagnostic reagents for healthcare markets across Australia, New Zealand and Asia.
YTD Price Performance: 2.33%
Average Trading Volume: 984,518
Technical Sentiment Signal: Sell
Current Market Cap: A$364.2M
Learn more about PGC stock on TipRanks’ Stock Analysis page.